NCT04890197 is a NA clinical trial of tahini in Breast Cancer, sponsored by National Nutrition and Food Technology Institute.

Who is sponsoring NCT04890197?

NCT04890197 is sponsored by National Nutrition and Food Technology Institute.

What drugs are being tested in NCT04890197?

Interventions in NCT04890197: tahini, control.

What condition does NCT04890197 study?

NCT04890197 studies Breast Cancer.

Is NCT04890197 still recruiting?

NCT04890197 is currently status unknown. Last updated 18 May 2021.

Last reviewed 2021-05-18 · How we verify

NCT04890197

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tahini and Dermatitis in Breast Cancer

Status unknown NA Last updated 18 May 2021

What this trial tests

NA trial testing tahini in Breast Cancer in 50 participants. Status unknown.

Timeline

8 May 2021

Primary endpoint
1 July 2021

15 July 2021

Quick facts

Lead sponsor	National Nutrition and Food Technology Institute
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	8 May 2021
Primary completion	1 July 2021
Estimated completion	15 July 2021

Drugs / interventions tested

tahini
control

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

National Nutrition and Food Technology Institute

Who can join

Adults 18 to 70, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the effect of tahini on acute radiation dermatitis in breast cancer (BC) patients undergoing radiotherapy (RT). 50 eligible BC patients will randomly assign to consume tahini 48 gr per day during and 1 week after RT or with no intervention (control group). The radiation dermatitis will be assessed weekly according to the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of Cancer (RTOG/EORTC) scales.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets.
Wei W, Ren Y, Lan J, Yi J, et al · · 2026 · PMID 41507636 · DOI 10.1186/s43556-025-00358-4

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other National Nutrition and Food Technology Institute trials

Trials by the same sponsor.

NCT06900946 — Evaluation of the Effects of Gluten Free Diet on Clinical Symptoms and Glycemic Index in Type 2 Diabetic Patients With N · NA · enrolling by invitation
NCT06351696 — The Effects of Bromelain Supplement in Patients With Ulcerative Colitis · NA · recruiting
NCT06353633 — The Effect of Exclusion Diet for Crohn's Disease Plus Enteral Nutrition on Children and Adolescents With Crohn's Disease · NA · not yet recruiting
NCT06160830 — The Effects of Synbiotic on Cardiovascular and Bone Metabolism Markers in Transplanted Kidney Patients · NA · unknown
NCT06096558 — The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04890197 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Nutrition and Food Technology Institute
Last refreshed: 18 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04890197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing